Tendinitis is an important disease that leads to lameness and decreased performance in equine athletes and results
in high costs associated with therapy due to a long recovery period and a high rate of recurrence. Although, several
treatments for equine tendinitis have been described, few are effective in significantly improving the quality of the extracellular
matrix and reducing the rate of recurrence. The use of cell therapy with mesenchymal stem cells (MSCs) derived
from various sources has received much attention because of its therapeutic potential for equine tendinitis. In this
paper, we review patents on stem cell therapy and the specific use of MSCs for the treatment of equine tendinitis.
Keywords: Adipose tissue, adult stem cells, bone marrow, cell therapy, equine, tendinitis, STEM CELLS, MESENCHYMAL STEM CELLS (MSCS), CELL THERAPY, TENOGENIC DIFFERENTIATION
Rights & PermissionsPrintExport